Population Pharmacokinetics of Adalimumab in Juvenile Idiopathic Arthritis Patients: A Retrospective Cohort Study Using Clinical Care Data
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Population Pharmacokinetics of Adalimumab in Juvenile Idiopathic Arthritis Patients: A Retrospective Cohort Study Using Clinical Care Data ; volume:26 ; number:4 ; day:17 ; month:4 ; year:2024 ; pages:441-450 ; date:7.2024
Pediatric drugs ; 26, Heft 4 (17.4.2024), 441-450, 7.2024
- Creator
-
Nassar-Sheikh Rashid, Amara
Hooijberg, Femke
Bergkamp, Sandy C.
Gruppen, Mariken P.
Kuijpers, Taco W.
Nurmohamed, Mike
Rispens, Theo
Wolbink, Gertjan
Berg, J. Merlijn van den
Schonenberg-Meinema, Dieneke
Mathôt, Ron A. A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40272-024-00629-7
- URN
-
urn:nbn:de:101:1-2409122103416.861409685852
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nassar-Sheikh Rashid, Amara
- Hooijberg, Femke
- Bergkamp, Sandy C.
- Gruppen, Mariken P.
- Kuijpers, Taco W.
- Nurmohamed, Mike
- Rispens, Theo
- Wolbink, Gertjan
- Berg, J. Merlijn van den
- Schonenberg-Meinema, Dieneke
- Mathôt, Ron A. A.
- SpringerLink (Online service)
Other Objects (12)
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis
Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Juvenile idiopathische Arthritis – Adalimumab – sicher und effizient
Administration of routine preventative vaccinations in children with polyarticular juvenile idiopathic arthritis receiving adalimumab
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab
Haptoglobin in Juvenile Idiopathic Arthritis
Juvenile idiopathic arthritis-associated uveitis
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis
Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Juvenile idiopathische Arthritis – Adalimumab – sicher und effizient
Administration of routine preventative vaccinations in children with polyarticular juvenile idiopathic arthritis receiving adalimumab
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab
Haptoglobin in Juvenile Idiopathic Arthritis
Juvenile idiopathic arthritis-associated uveitis
Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis
Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial
Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis
Juvenile idiopathische Arthritis – Adalimumab – sicher und effizient
Administration of routine preventative vaccinations in children with polyarticular juvenile idiopathic arthritis receiving adalimumab
Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases
Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab
Haptoglobin in Juvenile Idiopathic Arthritis